| Bone-anchored hearing aid abutment skin overgrowth reduction with clobetasol. | |
| | |
MedLine Citation:
|
PMID: 19041511 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: The bone-anchored hearing aid (BAHA) osseointegrated cochlear stimulator can treat hearing loss in a variety of clinical situations. Occasionally skin/scar overgrowth may cover the abutment. This overgrowth interferes with affixing the BAHA to the abutment. Surgical scar revision/excision has been used to treat this problem. Clobetasol (0.05%), a steroid gel, can reduce skin overgrowth. Experience with skin overgrowth and the efficacy of clobetasol to treat this problem was reviewed. SUBJECTS AND METHODS: The authors conducted a retrospective analysis of patients who underwent BAHA abutment implantation from January 2003 through December 2006. RESULTS: Eighty-eight patients (2 patients received bilateral BAHAs) were reviewed. Twenty (22%) of 90 sites developed overgrowth. Thirteen of 20 sites were treated with clobetasol. The overgrowth resolved in 11 (85%) of 13 sites after treatment. Patients with incomplete skin graft survival were significantly more likely to develop skin overgrowth (P = 0.0017). CONCLUSION: Clobetasol is an effective treatment for abutment skin/scar overgrowth. Clobetasol allows patients to resume BAHA use and obviates the need for scar revision. |
| | |
Authors:
|
Michael T Falcone; David M Kaylie; Robert F Labadie; David S Haynes |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery Volume: 139 ISSN: 0194-5998 ISO Abbreviation: Otolaryngol Head Neck Surg Publication Date: 2008 Dec |
Date Detail:
|
Created Date: 2008-12-01 Completed Date: 2009-03-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8508176 Medline TA: Otolaryngol Head Neck Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 829-32 Citation Subset: IM |
Affiliation:
|
Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN 37221, USA. michael.falcone@vanderbilt.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Child Child, Preschool Cicatrix / drug therapy* Clobetasol / administration & dosage, therapeutic use* Female Gels Glucocorticoids / administration & dosage, therapeutic use* Hearing Aids* Hearing Loss / rehabilitation* Humans Male Mastoid / surgery* Middle Aged Retrospective Studies Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Gels; 0/Glucocorticoids; 25122-41-2/Clobetasol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Connexins within the rat larynx.
Next Document: Demagnetization of cochlear implants and temperature changes in 3.0T MRI environment.